MarketPeel
Insider Trading Intelligence
AD

Allene M. Diaz

IONS
DIRECTOR · IONIS PHARMACEUTICALS INC · CIK 0001773314
FILING MIX · LIFETIME53%/47%
BUYS
18
SELLS
16
TOTAL VALUE
$7.46M
COMPANIES
1
ACTIVE SINCE
Jul 2021
HOLDINGS NOW
13,922
AVG SELL PX
$78.40
TRADE KIND
SHOWING 34 / 34
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 13 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Allene M. Diaz, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+71.43%-1.89%-1.01%-0.88%-2.33%
14d7+85.71%+2.30%-2.14%+4.44%+0.04%
30d7+85.71%+1.99%-1.85%+3.85%-1.32%
60d7+71.43%+4.90%+2.11%+2.79%-10.22%
90d7+71.43%+3.55%+0.00%+8.27%-5.42%
180d7(3 pending)+50.00%+14.75%+5.49%+9.26%-7.86%
1y7(4 pending)+66.67%-2.78%+15.15%-17.94%-25.74%
2y7(6 pending)+0.00%+4.29%+41.73%-37.44%-37.44%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
IONS · 13,922 shares · as of Jul 7, 2026
014,67229,34544,01758,68920222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 18 buys / 16 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
10,111$47.11$476.3K13,922Jul 7, 2026Jul 9, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE
10,1110Jul 7, 2026Jul 9, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
10,111$85.42$863.6K3,811Jul 7, 2026Jul 9, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,3017,521Jul 1, 2026Jul 6, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,3695,369Jul 1, 2026Jul 6, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE
12,0000Mar 3, 2026Mar 5, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
14,608$79.88$1.17M4,816Mar 3, 2026Mar 5, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
1,005$80.80$81.2K3,811Mar 3, 2026Mar 5, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
10,321$41.08$424.0K28,689Mar 3, 2026Mar 5, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
18,000$40.05$720.9K58,689Mar 3, 2026Mar 5, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE
10,3210Mar 3, 2026Mar 5, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE
18,0000Mar 3, 2026Mar 5, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
12,000$38.06$456.7K40,689Mar 3, 2026Mar 5, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
39,265$79.11$3.11M19,424Mar 3, 2026Mar 5, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
1,427$42.53$60.7K18,368Aug 22, 2025Aug 26, 2025View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
4,07919,795Jul 15, 2025Jul 17, 2025View →
IONS
IONIS PHARMACEUTICALS INC
SALE
4,0795,220Jul 15, 2025Jul 17, 2025View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
11,51811,518Jul 1, 2025Jul 2, 2025View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,2209,299Jul 1, 2025Jul 2, 2025View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
737$50.17$37.0K15,716Jul 16, 2024Jul 16, 2024View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
900$48.94$44.0K16,453Jul 16, 2024Jul 16, 2024View →
IONS
IONIS PHARMACEUTICALS INC
SALE
4,6774,079Jul 15, 2024Jul 16, 2024View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
4,67717,353Jul 15, 2024Jul 16, 2024View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
10,11110,111Jul 1, 2024Jul 2, 2024View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
4,0798,756Jul 1, 2024Jul 2, 2024View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
657$41.05$27.0K12,676Aug 1, 2023Aug 2, 2023View →
IONS
IONIS PHARMACEUTICALS INC
SALE
5,3334,677Jul 17, 2023Jul 19, 2023View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
5,33313,333Jul 17, 2023Jul 19, 2023View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
8,0008,000Jul 15, 2022Jul 18, 2022View →
IONS
IONIS PHARMACEUTICALS INC
SALE
8,0005,333Jul 15, 2022Jul 18, 2022View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
12,00012,000Jul 1, 2022Jul 5, 2022View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,33313,333Jul 1, 2022Jul 5, 2022View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
8,0008,000Jul 15, 2021Jul 19, 2021View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
18,00018,000Jul 1, 2021Jul 6, 2021View →
Other insiders · IONS
Loading peer insiders…
About this filer
CIK 0001773314
ROLE
Director
PRIMARY
IONS
COMPANIES
1
ACTIVE SINCE
Jul 2021
MARKETPEEL · /INSIDER/0001773314DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback